BMPR2 and pulmonary arterial hypertension: The replacement of defective BMPR2 with exogenous wild-type receptor to PAH-affected vascular cells was explored via nebulized intratracheal delivery of adenovirus expressing BMPR2 in monocrotaline-treated (MCT) rat model systems.